Oruka Therapeutics, Inc. ($ORKA)
Filing Information
| Accession Number | 0000907654-26-000035 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 15, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
21,000
Total Value
$514,069.56
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Apr 15, 2026 | Exercise/Conversion | 3,500 | $6.84 | $23,940.00 | 36,877 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 15, 2026 | Exercise/Conversion | 3,500 | $7.80 | $27,300.00 | 40,377 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 15, 2026 | Sale | 4,227 | $65.73 | $277,836.91 | 36,150 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 15, 2026 | Sale | 2,273 | $66.56 | $151,300.65 | 33,877 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Apr 15, 2026 | Sale | 500 | $67.38 | $33,692.00 | 33,377 | Direct | โ | View Details | |
Chief Medical Officer | Employee Stock Option (right to buy) | Derivative | Apr 15, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 211,063 | Direct | โ | View Details | |
Chief Medical Officer | Employee Warrant (right to buy) | Derivative | Apr 15, 2026 | Exercise/Conversion | 3,500 | $0.00 | $0.00 | 182,492 | Direct | โ | View Details |